[Prognostic value of sentinel lymph node in Merkel cell carcinoma of the head and neck].

M Penicaud, S Cammilleri, R Giorgi, D Taïeb, J J Grob, A Giovanni, P Dessi, N Fakhry
{"title":"[Prognostic value of sentinel lymph node in Merkel cell carcinoma of the head and neck].","authors":"M Penicaud,&nbsp;S Cammilleri,&nbsp;R Giorgi,&nbsp;D Taïeb,&nbsp;J J Grob,&nbsp;A Giovanni,&nbsp;P Dessi,&nbsp;N Fakhry","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Merkel cell carcinoma (MCC) is a rare neuroendocrine skin tumor. The aim of our study was to analyze the prognosis of patients operated on for CCM and having no lymph node involvement after analysis of sentinel lymph node (SLN).</p><p><strong>Material and method: </strong>This was a retrospective study of 10 cases of CCM stage I or II who received the SLN technique in our institution between 2003 and 2010. RESULTS Among the 10 patients, 7 had an identification of at least one SLN, among which the node could be surgically removed in 6 cases. In cases of failure of SLN technique, a neck dissection +/- parotidectomy was performed. No lymph node metastasis was found in our series. Mean follow-up was 38 months. The overall survival rate was 100% at 2 years and 50% at 5 years. The Disease-free survival was 85% at 2 and 5 years.</p><p><strong>Conclusion: </strong>Our results show that the technique of sentinel lymph node is a reliable tool for evaluating nodal status of patients with CCM and that pN0 patients have a good prognosis.</p>","PeriodicalId":76469,"journal":{"name":"Revue de laryngologie - otologie - rhinologie","volume":"134 2","pages":"75-9"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue de laryngologie - otologie - rhinologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin tumor. The aim of our study was to analyze the prognosis of patients operated on for CCM and having no lymph node involvement after analysis of sentinel lymph node (SLN).

Material and method: This was a retrospective study of 10 cases of CCM stage I or II who received the SLN technique in our institution between 2003 and 2010. RESULTS Among the 10 patients, 7 had an identification of at least one SLN, among which the node could be surgically removed in 6 cases. In cases of failure of SLN technique, a neck dissection +/- parotidectomy was performed. No lymph node metastasis was found in our series. Mean follow-up was 38 months. The overall survival rate was 100% at 2 years and 50% at 5 years. The Disease-free survival was 85% at 2 and 5 years.

Conclusion: Our results show that the technique of sentinel lymph node is a reliable tool for evaluating nodal status of patients with CCM and that pN0 patients have a good prognosis.

[头颈部默克尔细胞癌前哨淋巴结的预后价值]。
梅克尔细胞癌(MCC)是一种罕见的神经内分泌皮肤肿瘤。本研究的目的是分析未累及淋巴结的CCM患者在前哨淋巴结(SLN)分析后的预后。材料和方法:本研究是对2003年至2010年间在我院接受SLN技术治疗的10例I期或II期CCM患者的回顾性研究。结果10例患者中,7例至少有1个淋巴结转移,其中6例可手术切除。在SLN技术失败的情况下,进行颈部清扫+/-腮腺切除术。本组病例均未发现淋巴结转移。平均随访38个月。2年生存率为100%,5年生存率为50%。2年和5年无病生存率为85%。结论:前哨淋巴结技术是评估CCM患者淋巴结状态的可靠工具,pN0患者预后良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信